MRKR
USDMarker Therapeutics Inc. Common Stock
$0.902-0.048 (-5.042%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.950
High
$0.956
Low
$0.876
Volume
0.10M
Company Fundamentals
Market Cap
11.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.02M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.81Current $0.902High $5.95
Related News
GlobeNewswire
Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting
Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphomas showed encouraging preliminary efficacy data MT-601 demonstrated robust safety profile with no dose limiting toxicities (DLTs)
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.